ArticleThe American journal of case reports2026
Malignant Soft Tissue Tumor Mimicking Chronic Expanding Hematoma After a Long Clinical Course: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Chronic expanding hematoma (CEH) is a benign lesion characterized by slow enlargement over a prolonged period, and it can closely mimic soft tissue tumors. Differentiating CEH from malignant tumors is particularly challenging in patients with a long clinical course. CASE REPORT A 66-year-old man presented with a mass in the distal left upper arm that had been present for >10 years. He was referred to the Orthopaedic Department for suspected malignancy. Initial contrast-enhanced magnetic resonance imaging revealed a cystic lesion, and positron emission tomography/computed tomography revealed fluorodeoxyglucose (FDG) uptake in the septal components of the lesion and in the ipsilateral axillary lymph nodes. Incisional biopsy identified only hematoma components, and the lesion was diagnosed as consistent with CEH. Although conservative treatment, including embolization, drainage, and sclerotherapy, was applied, the mass rapidly enlarged 10 months later. Follow-up imaging revealed a markedly enlarged multilocular cystic lesion containing newly developed solid components with markedly increased FDG uptake. Left shoulder disarticulation with axillary lymph node dissection was subsequently performed. Histopathological examination of the resected tissue sample revealed an undifferentiated malignant tumor that could not be distinguished as a sarcoma or a carcinoma. CONCLUSIONS This case shows that lesions initially considered consistent with CEH can later reveal an underlying malignant tumor or possible malignant transformation. Careful interpretation of histopathology results, awareness of potential sampling error, and meticulous radiological evaluation with close follow-up are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.